Denali Therapeutics Inc. ($DNLI)
Filing Information
| Accession Number | 0001724310-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 6, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
35,198
Total Value
$580,767.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 6, 2026 | Sale | 35,198 | $16.50 | $580,767.00 | 296,833 | Direct | โ | View Details |